Elfabrio® (pegunigalsidase alfa-iwxj)
for Fabry Disease

Elfabrio (pegunigalsidase alfa-iwxj) is an enzyme replacement therapy for adults with Fabry disease. It replaces the missing alpha-galactosidase-A enzyme, helping to break down and prevent the buildup of globotriaosylceramide (Gb3), which can lead to heart problems, strokes, kidney failure, and other symptoms.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Fabry Disease